Korsana Biosciences | RoundOS

Weekly digest by email

Loading companies…

Korsana Biosciences | RoundOS

Weekly digest by email

Funding history

1 round · 1 with disclosed amounts

Announced	Round	Amount	Investors
Feb 18, 2026	Series A	$175M	Fairmount — Role not disclosedForesite Capital — Role not disclosedJanus Henderson Investors — Role not disclosedJ.P. Morgan Life Sciences Private Capital — Role not disclosedSanofi Ventures — Role not disclosedTCGX — Role not disclosedVenrock Healthcare Capital Partners — Role not disclosedWellington Management — Role not disclosed

Investors

FairmountSeries A Foresite CapitalSeries A Janus Henderson InvestorsSeries A J.P. Morgan Life Sciences Private CapitalSeries A Sanofi VenturesSeries A TCGXSeries A Venrock Healthcare Capital PartnersSeries A Wellington ManagementSeries A

Coverage

Feb 18, 2026Korsana Biosciences · Series A

Similar companies

AusperBioDevelops oligonucleotide therapeutics targeting chronic hepatitis B$120M · Series C

MetriportOpen-source healthcare data infrastructure unifying patient records for clinicians$26M · Series A

ProFound TherapeuticsUses AI and proteomics to discover drug targets and biomarkers for preeclampsia and eclampsia$35M · Strategic

Sources

korsana.com ↗